China NMPA Product Recall - Intramedullary nail surgical tools

The National Medical Products Administration (NMPA) issued a notice regarding a voluntary recall initiated by Biomet Trauma for specific batches of its intramedullary nail surgical tools. The recall targets reconstruction soft tissue cannulas (Model 14-442008, batches 76428, 2095181) and reconstruction anchoring arms (Model 14-442018, batches 290610, 290620, 386780). The primary issue identified is an incompatibility between the new version of the reconstruction soft tissue cannula and the old version of the anchoring arm. This mismatch results in an excessive gap during use, which can prevent surgeons from performing precise operations and potentially lead to surgical delays. The regulatory framework overseeing this action is the NMPA (formerly CFDA), which published the recall details and supervises medical device safety in China. While Biomet Trauma (Shanghai) Trading Co., Ltd. distributes these products, the affected batches were not sold in China, and no related complaints have been recorded domestically. However, the NMPA requested all provincial and municipal food and drug administrations to enhance their oversight and management of similar products to prevent future issues and ensure regulatory compliance.